Skip to main content
Advanced Biomedical Research logoLink to Advanced Biomedical Research
. 2015 Jan 30;4:22. doi: 10.4103/2277-9175.150388

Geranisetron versus gabapentin in preventing postoperative nausea and vomiting after middle ear surgery in adults: A double-blinded randomized clinical trial study

Morteza Heidari 1, Azim Honarmand 1,, Mohammadreza Safavi 1, Mohsen Chitsazi 1, Farnaz Khalighinejad 1
PMCID: PMC4333427  PMID: 25709987

Abstract

Background:

The incidence of postoperative nausea and vomiting (PONV) after middle ear surgery is high. In this study we want to compare the effects of intravenous granisetron and oral gabapentin as a premedication before surgery on the incidence and severity of PONV after middle ear surgery in adult patents.

Materials and Methods:

We enrolled 90 patients that were randomly divided into the three groups of 30 in each. Group I received granisetron 3 mg iv 2 minutes before induction of anesthesia; Group II received oral gabapentin 300 mg 1 hour before anesthesia and Group III received placebo. The incidence and severity of PONV were recorded each 15 minutes in the post-anesthesia care unit (PACU) and each 8 hours until 24 hours after discharge from the PACU.

Result:

The incidence and severity of nausea and vomiting at different time intervals in Groups I and Group II was significantly lower compared with Group III (P < 0.05). There was no significant difference in the incidence of side effects of study drug administration including respiratory depression, apnea, extra pyramidal disorders, drowsiness, dizziness, vertigo and headache in three groups.

Conclusion:

The study was shown that using gabapentin and granisetron have equal anti-emetic effects, but significant differences were seen between these two groups compared to the control group. These submit the efficiency of these drugs in preventing PONV.

Keywords: American social anesthesia, 5HT3 receptors, gabapentin, geranisetrone, post operating nausea and vomiting (PONV), visual analogues scale

INTRODUCTION

Postoperative nausea and vomiting (PONV) is the one of the most unpleasant complications.[1,2,3,4] PONV is an unpleasant feeling that are more distressing for patients than pain.[3,5,6] The etiology of PONV is multi-factorial[1,2,7,8] and its occurrence depends on duration of surgery, the type of drugs used during anesthesia,[4,9] the technique of anesthesia, age, sex, and smoking habit.[10,11,12] PONV increases intraocular pressure, increase intracranial pressure,[13] causes wound dehiscence, prolongs duration of stay in the recovery room and hospital.[14,15,16,17,18] Also, PONV is an uncommon cause of aspiration, dehydration, electrolytes disorder and even death[4] especially in children and elderly patients[19] and increase the cost of treatment.[20]

To prevent PONV, different kinds of drugs can be used including promethazine, droperidol, ondansetron, dexamethasone and propofol.[1,2,6,21,22,23] Despite using different kinds of drugs, PONV is a common side effect yet.[2,3,5,6] Each drug used has their own risks and benefits. For example deroperidol can make dry mouth.[1] Antagonists of 5HT3 receptors can cause prolonged QT interval in ECG or even cardiac arrest.[6]

Khademi et al.[24] showed that using oral gabapentin (an anticonvulsant) before surgery significantly reduced the incidence of PONV after open cholecystectomy. Papadima and colleagues[25] reported that intravenous administration of granisetron (a selective serotonin 5-hydroxytryptamine type 3 (5-HT3) receptor antagonists) before surgery reduced significantly the incidence of nausea after total thyroidectomy.

There were no previous studies which compare the efficacy of gabapentin versus granisetron in reducing PONV. So, we design the present study to compare the effect of intravenous granisetron and oral gabapentin as a premedication before surgery on the incidence and severity of nausea and vomiting after the middle ear surgery in adult patients.

MATERIALS AND METHODS

The study is a randomized, double-blinded placebo controlled clinical trial that was done from November 2008 to November 2010 after obtaining institutional approval from Ethic Committee of our University and written informed consent from the patients. The inclusion criteria were patients with ASA I and ASA II, aged between 18 and 60 years, non-pregnant or lactating females, not be in menstruation period, without history of addiction or using anti-vomiting drugs, motion sickness, obesity (body mass index more than 30), central nervous system disorders especially cerebella problems who were candidate for middle ear surgery. If technique of anesthesia was changed or there was uncontrolled bleeding during surgery, the patients were excluded from the study.

If we considered 0.8 power (type II statistical error 20%) to detect a significant difference between three groups with P = 0.05 (type I statistical error 0.05), 30 patients per group must be enrolled into our study.

No premedication was given to the patients. Before induction of anesthesia, the patients were informed from using Visual Analogue Score Scale (VAS, 0 = no nausea, 10 = the most severe nausea experienced) for recording of severity of nausea by a nurse. The patients were randomized into three groups by using a computer generated randomization method. Group I received 3 mg iv in a volume of 3 ml 2 minutes before induction of anesthesia; Group II received oral gabapentin 300 mg 1 hour before induction of anesthesia; Group III received placebo. The study drugs were administered by a physician who was not involved in data recording. Data gathering was performed by a nurse who was not informed from the study group allocation.

The standard monitoring included EKG, pulse oximetry and noninvasive blood pressure monitoring. Induction of anesthesia was done by injecting fentanyl 2 μg/kg, sodium thiopenta 5 mg/kg and atracurium 0.6 mg/kg for muscle relaxation. After 3 minutes mask ventilation under oxygen, laryngoscopy and endotracheal intubation was performed. Maintenance of anesthesia was done using isoflurane 1.2% in 50% N2O in oxygen and morphine for analgesia. At the end of surgery, neuromuscular blockade was reversed by neostigmine 0.04 mg/kg and atropine 0.02 mg/kg iv. Mean arterial blood pressure (MAP), heart rate (HR) and peripheral oxygen saturation (Spo2) were recorded throughout surgery each 15 minutes followed by recording at recovery room every 15 minutes and then after each 8 hours till 24-hours. After operation, the incidence of PONV, severity of PONV and the first time for occurrence of PONV were recorded. The severity of PONV was recorded by using VAS.

The sedation score of patients after surgery was recorded by the following scale:

  • Complete consciousness

  • Open eyes with sleepy mood

  • Closed eyes with good consciousness

  • Not having good consciousness

  • No consciousness.

Data were presented as mean ± SD or numbers (%). Statistical analysis was performed using the SPSS 16 statistical software package (SPSS Inc., Chicago, IL, USA). Quantitative data were analyzed by using one way ANOVA with Bonferroni correction. Qualitative data were analyzed by using the Chi-square test. A P value less than 0.05 was considered statistically significant.

RESULTS

The demographic and clinical data including sex, age, BMI, duration of surgery, duration of recovery stay and duration of anesthesia was not significantly different among three groups (P > 0.05) [Table 1]. The incidence and severity of nausea was significantly lower in Group I and Group II in comparison with Group III [P < 0.05, Tables 2 and 3]. Also, the incidence of vomiting was significantly lower in Group I and Group II in comparison with Group III [P < 0.05, Table 4]. There was no significant difference between Group I with Group II with respect to the incidence of nausea and vomiting and severity of nausea (P > 0.05). The first time for occurrence of vomiting was significantly longer in Group I and Group II compared with Group III [P < 0.05, Table 5]. No significant was noted between Group I and Group II in this regard.

Table 1.

Demographics and clinical data of patients in three groups

graphic file with name ABR-4-22-g001.jpg

Table 2.

Incidence of nausea at different time interval in three groups

graphic file with name ABR-4-22-g002.jpg

Table 3.

Severity of nausea at different time interval in three groups

graphic file with name ABR-4-22-g003.jpg

Table 4.

Incidence of vomiting at different time interval in three groups

graphic file with name ABR-4-22-g004.jpg

Table 5.

The first time for occurrence of vomiting in three groups

graphic file with name ABR-4-22-g005.jpg

The level of sedation in different time intervals was not significantly different among three groups (P > 0.05). There was no significant difference in the incidence of side effects including respiratory depression, apnea, extra pyramidal disorders, drowsiness, dizziness, vertigo and headache among three groups [P > 0.05, Table 6].

Table 6.

The incidence of adverse effects in three groups

graphic file with name ABR-4-22-g006.jpg

The study showed that using Gabapentin and Granisetron have equal anti emetic effects, but significant differences seen between these two groups compared to the control group. These submit the efficiency of these drugs in preventing PONV [Figure 1].

Figure 1.

Figure 1

The comparisons anti-emetic effects in three groups gabapentin, granisetron and control up to 24 hours after surgery

DISCUSSION

Our study showed that using granisetron 3 mg iv 2 minutes before induction of anesthesia or using oral gabapentin 300 mg 1 hour before beginning of general anesthesia significantly reduced the incidence of nausea and vomiting and severity of nausea in comparison with placebo. No significant difference was noted between granisetron and gabapentin in prevention of PONV.

Nausea and vomiting after surgery are the most unpleasant complications.[1,2,3,4] The incidence of PONV is varies from 14% to 82%.[2,3,5,7,26,27] The etiology of PONV is not completely known but from the present data showed that stimulation of four groups of receptors are effective in prevention of PONV. These receptors are: Cholinergic (muscarinic), dopaminergic (D2), histaminergic (H1) and seretoninergic (5HT3).[7] Recently it was shown that antagonists of neurokinin receptors (NK1) were effective in treatment of PONV.[2,5]

Papadima et al.[25] in a clinical trial study showed that granisetron 3 mg given before induction of anesthesia significantly reduced the incidence of PONV after total thyroidectomy. In another performed by Ganjare and colleagues[28] it was shown that granisetron 1 mg administered before induction of anesthesia was effective for prevention of PONV. They also showed that granisetron with 1 mg dose was safer than ondansetron 8 mg in this regards because granisetron caused less QT prolongation than ondansetron.

The exact mechanism of granisetron for reducuing PONV has not been explained but it was postulated that it acts by stimulation of 5HT3 receptors which have anti-emetic effects.[28] Khademi et al.[24] showed that administration of oral gabapentin 2 hours before surgery significantly reduced the incidence of PONV after open cholecystectomy. Also, the previous studies[29,30] showed that oral gabapentin had significant effect in reducing the incidence and severity of PONV after laparoscopic surgery. It has been postulated that anti-emetic effect of gabapentin is generated by reducing the activity of tachykinin neurotransmitter.[31]

Our study had some limitation; we used only one dosage of gabapentin or granisetron. It was not clear that using different dosage of both drugs have similar effect in reducing PONV. Also, the efficacy of both drugs in reducing PONV was shown only in middle ear surgery. It is suggested that similar studies perform in the other surgeries which were accompanied with significant PONV.

In conclusion our study showed that using oral gabapentin 300 mg 1 hour before surgery had similar and comparable effect to injection of granisetron 3 mg intravenously 2 minutes before induction of anesthesia in reducing the incidence of PONV and severity of nausea after middle ear surgery in adults without causing significant adverse effects.

ACKNOWLEDGMENT

The authors wish to sincerely thank the support of all the colleagues in Kashani Hospital Medical Center affiliated to Isfahan University of Medical Sciences in Isfahan, Iran. Furthermore, our special thanks go to the patients, who wholeheartedly and actively assisted us to carry out this research. No conflict of interest existed. This prospective randomized observational study was approved by the Ethics Committee of our university, (Anesthesiology and Critical Care Research Center, Isfahan University of Medical Sciences, Isfahan, Iran) and all patients gave written, informed consent.

Footnotes

Source of Support: Anesthesiology and Critical Care Research Center, Isfahan University of Medical Sciences, Isfahan, Iran

Conflict of Interest: None declared.

REFERENCES

  • 1.Miller RD. Anesthesia. In: Fleisher LA, Macario A, editors. The postanesthesia care unit. 6th ed. Pennsylvania: Elsevier; 2010. pp. 2703–27. [Google Scholar]
  • 2.Habib AS, Gan TJ. Evidence-based management of postoperative nausea and vomiting: A review. Can J Anesth. 2004;51:326–41. doi: 10.1007/BF03018236. [DOI] [PubMed] [Google Scholar]
  • 3.Kazemi-Kjellberg F, Henzi I, Tramèr MR. Treatment of established postoperative nausea and vomiting: A quantitative systematic review. BMC Anesthesiol. 2001;1:2. doi: 10.1186/1471-2253-1-2. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 4.Splinter WM, MacNeill HB, Menard EA, Rhine EJ, Roberts DJ, Gould MH. Midazolam reduces vomiting after tonsillectomy in children. Can J Anaesth. 1995;42:201–3. doi: 10.1007/BF03010676. [DOI] [PubMed] [Google Scholar]
  • 5.Korttila K, Alahuhta S, Ali-Melkkila DT, Tarkkila DP, Hynynen DM. Prevention of postoperative nausea and vomiting-studies on different antiemetics, their combinations and dosing regimens. Biomedicum Helsinki. 2003;26:1–78. [Google Scholar]
  • 6.Kreis ME. Postoperative nausea and vomiting. Auton Neurosci. 2006;129:86–91. doi: 10.1016/j.autneu.2006.07.017. [DOI] [PubMed] [Google Scholar]
  • 7.Sharma S, Abdullah N. A comparison of commonly used anti-emetics for the prevention of emetic sequelae after a major gynaecological surgery. Singapore Med J. 2000;41:147–50. [PubMed] [Google Scholar]
  • 8.Habib AS, White WD, Eubanks S, Pappas TN, Gan TJ. A randomized comparison of a multimodal management strategy versus combination antiemetics for the prevention of postoperative nausea and vomiting. Anesth Analg. 2004;99:77–81. doi: 10.1213/01.ANE.0000120161.30788.04. [DOI] [PubMed] [Google Scholar]
  • 9.Bianchin A, De Luca A, Caminiti A. Postoperative vomiting reduction after laparoscopic cholecystectomy with single dose of dexamethasone. Minerva Anestesiol. 2007;73:343–6. [PubMed] [Google Scholar]
  • 10.Jung JS, Park JS, Kim SO, Lim DG, Park SS, Kwak KH, et al. Prophylactic antiemetic effect of midazolam after middle ear surgery. Otolaryngol Head Neck Surg. 2007;137:753–6. doi: 10.1016/j.otohns.2007.07.024. [DOI] [PubMed] [Google Scholar]
  • 11.Buck DW, Mustoe TA, Kim JY. Postoperative nausea and vomiting in plastic surgery. Semin in Plast Surg. 2006;20:249–55. [Google Scholar]
  • 12.Rajesh P. Incidence of postoperative nausea and vomiting in elective oral and maxillofacial surgical procedure. Int J Oral Maxillofac Surg. 2007;36:1030. [Google Scholar]
  • 13.Heidari SM, Saryazdi H, Saghaei M. Effect of intravenous midazolam premedication on postoperative nausea and vomiting after cholecystectomy. Acta Anaesthesiol Taiwan. 2004;42:77–80. [PubMed] [Google Scholar]
  • 14.Bauer KP, Dom PM, Ramirez AM, O’Flaherty JE. Preoperative intravenous midazolam: Benefits beyond anxiolysis. J Clin Anesth. 2004;16:177–83. doi: 10.1016/j.jclinane.2003.07.003. [DOI] [PubMed] [Google Scholar]
  • 15.Arif AS, Kaye AD, Frost E. Postoperative nausea and vomiting-a review. Middle East J Anesthesiol. 2001;16:127–54. [PubMed] [Google Scholar]
  • 16.Habib AS, Chen YT, Taquchi A, Hu XH, Gan TJ. Postoperative nausea and vomiting following inpatient surgeries in a teaching hospital: A retrospective database analysis. Curr Med Res Opin. 2006;22:1093–9. doi: 10.1185/030079906X104830. [DOI] [PubMed] [Google Scholar]
  • 17.Grecu I, Vartic M, Avram V. A comparison of midazolam, droperidol and ondansetron in preventing postoperative nausea and vomiting after laparoscopic cholecystectomy. Eur J Anaesthesiol Suppl. 2000;17:120. [Google Scholar]
  • 18.Eberhart LH, Mauch M, Morin AM, Wulf H, Geldner G. Impact of a multimodal anti-emetic prophylaxis on patient satisfaction in high-risk patients for postoperative nausea and vomiting. Anaesthesia. 2002;57:1022–7. doi: 10.1046/j.1365-2044.2002.02822.x. [DOI] [PubMed] [Google Scholar]
  • 19.Grabowshka-Gawe³ A. Postoperative nausea and vomiting (PONV)-causes, prevention, treatement. Przegl Lek. 2005;62:1517–20. [PubMed] [Google Scholar]
  • 20.Williams KS. Postoperative nausea and vomiting. Surg Clin North Am. 2005;85:1229–41. doi: 10.1016/j.suc.2005.09.005. xi. [DOI] [PubMed] [Google Scholar]
  • 21. [Last accessed on 2013 Feb 10]. Available from: http://www.rch.org.au/anaes/pain_management/Postoperative_Nausea_Vomiting_PONV .
  • 22.Lee Y, Wang JJ, Yang YL, Chen A, Lai HY. Midazolam vs ondansetron for preventing postoperative nausea and vomiting: A randomised controlled trial. Anaesthesia. 2007;62:18–22. doi: 10.1111/j.1365-2044.2006.04895.x. [DOI] [PubMed] [Google Scholar]
  • 23.Rodolà F. Midazolam as an anti-emetic. Eur Rev Med Pharmacol Sci. 2006;10:121–6. [PubMed] [Google Scholar]
  • 24.Khademi S, Ghaffarpasand F, Heiran HR, Asefi A. Effects of preoperative gabapentin on postoperative nausea and vomiting after open cholecystectomy: A prospective randomized double-blind placebo-controlled study. Med Princ Pract. 2010;19:57–60. doi: 10.1159/000252836. [DOI] [PubMed] [Google Scholar]
  • 25.Papadima A, Gourgiotis S, Lagoudianakis E, Pappas A, Seretis C, Antonakis PT, et al. Granisetron versus tropisetron in the prevention of postoperative nausea and vomiting after total thyroidectomy. Saudi J Anaesth. 2013;7:68–74. doi: 10.4103/1658-354X.109817. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 26.Riad W, Altaf R, Abdulla A, Oudan H. Effect of midazolam, dexamethasone and their combination on the prevention of nausea and vomiting following strabismus repair in children. Eur J Anaesthesiol. 2007;24:697–701. doi: 10.1017/S0265021507000166. [DOI] [PubMed] [Google Scholar]
  • 27.Cho SY, Oh MK, Yeom JH, Shin WJ, Kim YC, Lee DH. The postoperative antiemetic effect of midazolam in patients undergoing appendectomy. Korean J Anesthesiol. 1999;37:1095–100. [Google Scholar]
  • 28.Ganjare A, Kulkarni AP. Comparative electrocardiographic effects of intravenous ondansetron and granisetron in patients undergoing surgery for carcinoma breast: A prospective single-blind randomised trial. Indian J Anaesth. 2013;57:41–5. doi: 10.4103/0019-5049.108560. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 29.Pandey CK, Priye S, Ambesh SP, Singh S, Singh U, Singh PK. Prophylactic gabapentin for prevention of postoperative nausea and vomiting in patients undergoing laparoscopic cholecystectomy: A randomized, double-blind, placebo-controlled study. J Postgrad Med. 2006;52:97–100. [PubMed] [Google Scholar]
  • 30.Pandey CK, Priye S, Singh S, Singh U, Singh RB, Singh PK. Preemptive use of gabapentin significantly decreases postoperative pain and rescue analgesic requirements in laparoscopic cholecystectomy. Can J Anaesth. 2004;51:358–63. doi: 10.1007/BF03018240. [DOI] [PubMed] [Google Scholar]
  • 31.Kong VK, Irwin MG. Gabapentin: A multimodal perioperative drug? Br J Anaesth. 2007;99:775–86. doi: 10.1093/bja/aem316. [DOI] [PubMed] [Google Scholar]

Articles from Advanced Biomedical Research are provided here courtesy of Wolters Kluwer -- Medknow Publications

RESOURCES